-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$358.20-4.91% Downside
Recent Analyst Forecasts and Stock Ratings
United Therapeutics Corporation Frequently Asked Questions
-
What analysts cover United Therapeutics Corporation?
United Therapeutics Corporation has been rated by research analysts at Argus Research, H.C. Wainwright, Jefferies, Oppenheimer, UBS, Wells Fargo in the past 90 days.